AU2001286242A1 - Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient - Google Patents
Urea derivative and adhesive-molecule inhibitor containing the same as active ingredientInfo
- Publication number
- AU2001286242A1 AU2001286242A1 AU2001286242A AU8624201A AU2001286242A1 AU 2001286242 A1 AU2001286242 A1 AU 2001286242A1 AU 2001286242 A AU2001286242 A AU 2001286242A AU 8624201 A AU8624201 A AU 8624201A AU 2001286242 A1 AU2001286242 A1 AU 2001286242A1
- Authority
- AU
- Australia
- Prior art keywords
- adhesive
- active ingredient
- same
- molecule inhibitor
- urea derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-281040 | 2000-09-14 | ||
JP2000281040 | 2000-09-14 | ||
PCT/JP2001/007990 WO2002022563A1 (en) | 2000-09-14 | 2001-09-14 | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001286242A1 true AU2001286242A1 (en) | 2002-03-26 |
Family
ID=18765763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001286242A Abandoned AU2001286242A1 (en) | 2000-09-14 | 2001-09-14 | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
Country Status (8)
Country | Link |
---|---|
US (1) | US20040039040A1 (en) |
EP (1) | EP1323709A1 (en) |
JP (1) | JPWO2002022563A1 (en) |
KR (1) | KR20030036724A (en) |
CN (1) | CN1458922A (en) |
AU (1) | AU2001286242A1 (en) |
CA (1) | CA2422135A1 (en) |
WO (1) | WO2002022563A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960597B2 (en) | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
MXPA04001144A (en) * | 2001-08-07 | 2004-07-08 | Banyu Pharma Co Ltd | Spiro compounds. |
US7842808B2 (en) | 2002-06-05 | 2010-11-30 | Bristol-Myers Squibb Company | Anti-migraine spirocycles |
US7220862B2 (en) | 2002-06-05 | 2007-05-22 | Bristol-Myers Squibb Company | Calcitonin gene related peptide receptor antagonists |
PT1539766T (en) * | 2002-06-05 | 2017-03-02 | Bristol Myers Squibb Co | Calcitonin gene related peptide receptor antagonists |
ES2219177B1 (en) * | 2003-05-05 | 2006-02-16 | Almirall Prodesfarma, S.A. | DERIVATIVES OF N- (2-PHENILETIL) SULFAMIDE AS ANTAGONISTS OF INTEGRIN ALFA4. |
JP2007524568A (en) * | 2003-12-05 | 2007-08-30 | ブリストル−マイヤーズ スクイブ カンパニー | Calcitonin gene-related peptide receptor antagonist |
GB0402812D0 (en) * | 2004-02-09 | 2004-03-10 | Tanabe Seiyaku Co | Novel compounds |
US20100150915A1 (en) | 2007-02-20 | 2010-06-17 | Stewart Edward J | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
JP5639039B2 (en) | 2008-04-11 | 2014-12-10 | メリマック ファーマシューティカルズ インコーポレーティッド | Human serum albumin linker and its conjugates |
JP5677972B2 (en) * | 2008-11-18 | 2015-02-25 | メリマック ファーマシューティカルズ インコーポレーティッド | Human serum albumin linker and its conjugates |
US20150202287A1 (en) | 2012-08-30 | 2015-07-23 | Merrimack Pharmaceuticals, Inc. | Combination therapies comprising anti-erbb3 agents |
AU2019373245C1 (en) | 2018-10-30 | 2022-10-27 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4β7 integrin |
US11174256B2 (en) | 2018-10-30 | 2021-11-16 | Gilead Sciences, Inc. | Imidazopyridine derivatives |
CR20210213A (en) | 2018-10-30 | 2021-06-24 | Gilead Sciences Inc | Quinoline derivatives as alpha4beta7 integrin inhibitors |
JP7189368B2 (en) | 2018-10-30 | 2022-12-13 | ギリアード サイエンシーズ, インコーポレイテッド | Compounds for inhibition of alpha4beta7 integrin |
AU2020329207B2 (en) | 2019-08-14 | 2024-02-29 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999020272A1 (en) * | 1997-10-21 | 1999-04-29 | Merck & Co., Inc. | Azapeptide acids as cell adhesion inhibitors |
ES2220140T3 (en) * | 1998-12-22 | 2004-12-01 | Tanabe Seiyaku Co., Ltd. | INHIBITORS OF THE MEDIUM ACCESSION OF CELLS BY ALFA 4 BETA 1 (A4B1) |
AU6909300A (en) * | 1999-08-20 | 2001-03-19 | Merck & Co., Inc. | Substituted ureas as cell adhesion inhibitors |
PT1214292E (en) * | 1999-09-24 | 2007-09-14 | Genentech Inc | Tyrosine derivatives |
WO2001032610A1 (en) * | 1999-10-29 | 2001-05-10 | Kaken Pharmaceutical Co., Ltd. | Urea derivative, process for producing the same, and medicine containing the urea derivative |
-
2001
- 2001-09-14 AU AU2001286242A patent/AU2001286242A1/en not_active Abandoned
- 2001-09-14 US US10/380,523 patent/US20040039040A1/en not_active Abandoned
- 2001-09-14 CA CA002422135A patent/CA2422135A1/en not_active Abandoned
- 2001-09-14 WO PCT/JP2001/007990 patent/WO2002022563A1/en not_active Application Discontinuation
- 2001-09-14 JP JP2002526816A patent/JPWO2002022563A1/en active Pending
- 2001-09-14 EP EP01965644A patent/EP1323709A1/en not_active Withdrawn
- 2001-09-14 KR KR10-2003-7002665A patent/KR20030036724A/en not_active Application Discontinuation
- 2001-09-14 CN CN01815662A patent/CN1458922A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20040039040A1 (en) | 2004-02-26 |
CA2422135A1 (en) | 2003-03-13 |
CN1458922A (en) | 2003-11-26 |
JPWO2002022563A1 (en) | 2004-01-22 |
WO2002022563A1 (en) | 2002-03-21 |
KR20030036724A (en) | 2003-05-09 |
EP1323709A1 (en) | 2003-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002253619A1 (en) | Heterocyclic compound and antitumor agent containing the same active ingredients | |
IL157070A0 (en) | Isoxazoline derivative and herbicide containing the same as the active ingredient | |
AU2001290257A2 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU2001236457A1 (en) | Compounds and compositions for delivering active agents | |
AU2001287299A1 (en) | Benzoylpyrazols and their use as herbicides | |
AU2001284985A1 (en) | Compounds and compositions for delivering active agents | |
AU2001244355A1 (en) | Heterobiarylsulphonamides and their use as pde 7 inhibitors | |
EP1067130A4 (en) | Triazolo derivatives and chemokine inhibitors containing the same as the active ingredient | |
AU2001277526A1 (en) | Substituted benzo-nitro-heterocycles and use thereof as herbicides | |
AU2001286242A1 (en) | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | |
AU2002328494A1 (en) | Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients | |
AU2001288277A1 (en) | Compounds and compositions for delivering active agents | |
AU2001288114A1 (en) | Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient | |
AU2001278772A1 (en) | Benzoic acid derivatives and drugs containing the same as the active ingredient | |
AU3078000A (en) | Heterocyclic compounds and antitumor agents containing the same as the active ingredient | |
AU5213300A (en) | 2-nh-pyridones and pyrimidones as mrs inhibitors | |
AU2001232238A1 (en) | Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient | |
AU2001277738A1 (en) | Piperidine derivatives and drugs containing these derivatives as the active ingredient | |
AU2001276027A1 (en) | Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors | |
AU2002216650A1 (en) | Triazine derivatives as lpaat-b inhibitors and uses thereof | |
AU2001230355A1 (en) | Benzoxazole derivatives and their use as pesticides | |
AU2001277561A1 (en) | Biphenyl derivatives and the use thereof as integrin inhibitors | |
AU2023801A (en) | Dihalopropenyloxybenzene derivatives and pesticides containing the same as the active ingredient | |
AU2001266124A1 (en) | 2-aminothiazoline derivatives and their use as no-synthase inhibitors |